Atea Pharmaceuticals (NASDAQ:AVIR) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.44) by 77.27 percent. This is a 70.59 percent increase over losses of $(0.34) per share from the same period last year.
Apple’s First App Store Transparency Report Reveals Jaw-Dropping Numbers: 1.7M Apps, 373M Weekly Searches, Rejections And More
Apple Inc.’s (NASDAQ:AAPL) first-ever App Store Transparency Report sheds light on fascinating statistics, including millions of submissions, rejections, government…
